Jul. 6, 2023
Paul Hastings accused of malpractice, denies claims
The defunct biotechnology company claims the firm’s “professional negligence” led to its demise and liquidation, with financial losses of over $300 million that forced it into bankruptcy.
Paul Hastings LLP on Wednesday denied accusations of malpractice made by a biotechnology company that alleged the firm caused it $300 million in losses, leading to bankruptcy, by mishandling procedures to remove the company’s founder and get a new CEO and board appointed.
Redwood Liquidating Co., formerly known as GenapSys Inc., claims in a lawsuit filed by Lesnick Prince & Pappas LLP in Los Angeles, that Paul Hastings’ “professional n...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In